• CalciMedica (NASDAQ: CALC) gains 6.9% holder via June 2026 private placement Stock Titan Fri, 03 Jul 2026 00:53:11 GMT
• deerfield mgmt hif l p net worth - insider trades and bio as of apr 22, 2026 Benzinga Thu, 09 Apr 2026 16:52:19 GMT
• essity ab (publ) (otcmkts:ettyf) trading down 10.2% – here’s what happened Defense World Wed, 01 Apr 2026 06:02:12 GMT
• latest calc news - calcimedica reports second quarter 2023 fin... Stock Titan Mon, 16 Mar 2026 16:15:16 GMT
• calc - calcimedica inc latest stock news & market updates Stock Titan Mon, 16 Mar 2026 16:15:16 GMT
• qlaris bio appoints fred guerard, pharm.d., as president and chief executive officer Business Wire Tue, 10 Mar 2026 07:00:00 GMT
• graybug vision (nasdaq:gray) trading up 10% – still a buy? Defense World Tue, 10 Mar 2026 06:15:51 GMT
• retinal vein occlusion market: high-growth opportunities for investors to 2034 – delveinsight | kodiak sciences, roche/chugai phar... Barchart.com Thu, 05 Mar 2026 14:34:06 GMT
• gensight biologics bolsters regulatory leadership in us and europe with two senior appointments PharmiWeb.com Wed, 18 Feb 2026 09:50:26 GMT
• financial survey: graybug vision (nasdaq:gray) vs. portage biotech (nasdaq:aton) Defense World Tue, 17 Feb 2026 06:13:29 GMT
• contrasting capstone (otcmkts:caps) and graybug vision (nasdaq:gray) Defense World Tue, 17 Feb 2026 06:13:29 GMT
• wet age-related macular degeneration market to experience notable growth in forecast span by 2034, delveinsight predicts | opthea ... Barchart.com Tue, 20 Jan 2026 08:00:00 GMT
• retinal vein occlusion pipeline 2025: therapies, moa insights, and key clinical trial updates by delveinsight openPR.com Thu, 15 Jan 2026 08:00:00 GMT
• graybug vision (nasdaq:gray) trading 12.7% higher – what’s next? Defense World Thu, 18 Dec 2025 08:00:00 GMT
• baltimore startup closer to opioid-free pain treatment with first-of-its-kind cell therapy that absorbs pain signals BioBuzz Sat, 13 Dec 2025 08:00:00 GMT
• reviewing graybug vision (nasdaq:gray) and china pharma (nyse:cphi) Defense World Sat, 29 Nov 2025 06:16:09 GMT
• graybug vision (nasdaq:gray) stock price down 0.6% – time to sell? Defense World Wed, 22 Oct 2025 07:00:00 GMT
• graybug vision (nasdaq:gray) trading up 2.3% – what’s next? Defense World Tue, 30 Sep 2025 07:00:00 GMT
• diabetic macular edema pipeline 2025: moa and roa insights, clinical trials status, and key companies involved by delveinsight | o... The Globe and Mail Tue, 02 Sep 2025 07:00:00 GMT
• juvenile macular degeneration treatment market is booming worldwide | major giants regeneron pharmaceuticals newstrail.com Thu, 21 Aug 2025 17:20:51 GMT
• what does calc's flat eps in 2023 suggest for future growth? AInvest Tue, 29 Jul 2025 12:36:06 GMT
• unexpected trends reshaping the ocular drug delivery market openPR.com Thu, 17 Jul 2025 14:15:00 GMT
• diabetic macular edema pipeline 2025: moa, roa, fda-approved drugs, and clinical trial progress assessment by delveinsight oxurion... Menafn Wed, 16 Jul 2025 14:06:22 GMT
• graybug vision (nasdaq:gray) shares up 11.9% – what’s next? Defense World Wed, 02 Jul 2025 10:49:21 GMT
• graybug vision (nasdaq:gray) trading down 2% – here’s why Defense World Sat, 07 Jun 2025 07:00:00 GMT
• hensoldt (otc:hnsdf) shares down 9.6% – here’s what happened Defense World Sat, 07 Jun 2025 07:00:00 GMT
• retinal vein occlusion drugs market 2034: clinical trials, ema, pdma, fda approvals, clinical revenue, statistics, medication, the... Barchart.com Fri, 06 Jun 2025 03:24:00 GMT
• retinal vein occlusion drugs market 2034: clinical trials, ema, pdma, fda approvals, clinical revenue, statistics, medication, the... Barchart.com Thu, 05 Jun 2025 03:08:00 GMT
• steppe gold (otcmkts:stpgf) trading up 1.3% – time to buy? Defense World Fri, 16 May 2025 09:45:57 GMT
• touchstone exploration (otcmkts:pbegf) shares down 6.6% – should you sell? Defense World Fri, 16 May 2025 07:00:00 GMT
• graybug vision (nasdaq:gray) stock price down 0.9% – here’s what happened Defense World Fri, 16 May 2025 07:00:00 GMT
• graybug vision stock hits 52-week low at $1.43 amid sharp decline Investing.com Australia Fri, 25 Apr 2025 07:00:00 GMT
• graybug vision (nasdaq:gray) trading down 1.7% – here’s what happened Defense World Thu, 24 Apr 2025 09:21:51 GMT
• graybug vision stock hits 52-week low at $1.43 amid sharp decline Investing.com Thu, 24 Apr 2025 07:00:00 GMT
• graybug vision stock hits 52-week low at $1.57 amid challenges by investing.com Investing.com South Africa Thu, 10 Apr 2025 00:35:46 GMT
• aviceda therapeutics appoints ophthalmology innovator and industry leader dr. emmett t. cunningham, jr. to board of directors Business Wire Wed, 09 Apr 2025 07:00:00 GMT
• fda approval expert with 10 successes strengthens aviceda's eye drug pipeline Stock Titan Wed, 09 Apr 2025 07:00:00 GMT
• graybug vision stock hits 52-week low at $1.57 amid challenges Investing.com Wed, 09 Apr 2025 07:00:00 GMT
• graybug vision stock hits 52-week low at $1.81 by investing.com Investing.com South Africa Tue, 01 Apr 2025 19:30:00 GMT
• graybug vision (nasdaq:gray) shares down 3.3% – time to sell? Defense World Sat, 22 Mar 2025 07:00:00 GMT
• graybug vision stock hits 52-week low at $1.83 amid challenges Investing.com Canada Thu, 13 Mar 2025 07:00:00 GMT
• graybug vision stock hits 52-week low at $1.95 amid challenges Investing.com Tue, 04 Mar 2025 08:00:00 GMT
• graybug vision (nasdaq:gray) trading down 3% – should you sell? Defense World Thu, 06 Feb 2025 08:00:00 GMT
• age-related macular degeneration treatment market size in the 7mm was ~usd 9,840 million in 2023,is further expected to grow by 20... The Globe and Mail Tue, 28 Jan 2025 00:11:11 GMT
• graybug vision reports board of directors change and appointment of new director Defense World Fri, 17 Jan 2025 08:00:00 GMT
• graybug vision (nasdaq:gray) trading down 4% – time to sell? Defense World Wed, 15 Jan 2025 08:00:00 GMT
• retinal vein occlusion market to expand significantly by 2034, states delveinsight report EIN News Tue, 14 Jan 2025 20:15:00 GMT
• graybug vision (nasdaq:gray) shares down 0.4% – should you sell? Defense World Tue, 24 Dec 2024 08:00:00 GMT
• diabetic macular edema market to expand significantly by 2034, openPR Thu, 19 Dec 2024 16:53:00 GMT
• graybug vision stock hits 52-week low at $2.65 amid market challenges Investing.com Canada Sat, 07 Dec 2024 09:56:29 GMT
• graybug vision stock hits 52-week low at $2.65 amid market challenges Investing.com Fri, 06 Dec 2024 08:00:00 GMT
• graybug vision (nasdaq:gray) shares up 1.5% – should you buy? Defense World Sat, 30 Nov 2024 07:26:59 GMT
• graybug vision suspends stock offering amid proposed public offering of calcimedica Defense World Sat, 02 Nov 2024 09:12:04 GMT
• concentra group holdings parent declares quarterly dividend on october 28, 2024, concentra group holdings parent, inc. (nyse: con)... Defense World Fri, 01 Nov 2024 06:06:26 GMT
• the united states retinal vein occlusion treatment market size & outlook, 2030 Grand View Research Sat, 19 Oct 2024 12:26:15 GMT
• ocular drug delivery technology industry size share growth trends and forecast analysis (2024-2034) IndiaPolitics.com Wed, 16 Oct 2024 11:21:34 GMT
• retinal disorder treatment market is going to boom |santen pharmaceutical, regeneron, graybug vision, takeda pharmaceuti – indiapo... IndiaPolitics.com Tue, 15 Oct 2024 05:18:05 GMT
• retinal vein occlusion market size is set for rapid growth as openPR Mon, 14 Oct 2024 07:00:00 GMT
• north america retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 13:23:29 GMT
• asia pacific retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 13:23:28 GMT
• the united states retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 13:18:25 GMT
• canada retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 13:11:06 GMT
• india retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 12:32:31 GMT
• mexico retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 12:10:40 GMT
• china retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 12:10:27 GMT
• italy retinal disorder treatment market size & outlook, 2030 Grand View Research Fri, 11 Oct 2024 12:10:21 GMT
• ocular drug delivery system market to witness amazing growth Elektrotransports.lv Thu, 10 Oct 2024 09:02:04 GMT
• opthea appoints chief medical officer and chief financial officer as company prepares for phase 3 topline data readouts in 2025 The Manila Times Tue, 08 Oct 2024 07:00:00 GMT
• retinal disorder treatment market share report, industry share and trends analysis by 2033 WhaTech Sat, 28 Sep 2024 07:00:00 GMT
• retinal disorder treatment market share report, industry share and trends analysis by 2033 WhaTech Fri, 27 Sep 2024 21:21:37 GMT
• retinal disorders treatment industry to set phenomenal growth Elektrotransports.lv Fri, 27 Sep 2024 06:47:16 GMT
• ocular drug delivery technology industry global analysis (2024-2034) – news North America Agile Program ... Sun, 15 Sep 2024 05:40:30 GMT
• opthea names senior leaders ahead of phase 3 wet amd data readout Eyes On Eyecare Tue, 10 Sep 2024 07:00:00 GMT
• retinal vein occlusion market to grow positively at a paltry cagr openPR Wed, 04 Sep 2024 16:24:00 GMT
• graybug vision (nasdaq:gray) versus perrigo (nyse:prgo) head-to-head survey Defense World Mon, 26 Aug 2024 07:00:00 GMT
• retinal disorders treatment market growing massively by santen pharmaceutical co lt, regenero, , graybug vision in – timc TIMC Thu, 11 Jul 2024 18:11:48 GMT
• siga technologies sees unusually high options volume (nasdaq:siga) American Banking and Market News Thu, 11 Jul 2024 07:00:00 GMT
• virtus duff & phelps clean energy etf (nysearca:vcln) trading up 1.8% American Banking and Market News Thu, 11 Jul 2024 06:22:25 GMT
• goldmining (tse:gold) shares up 0.8% American Banking and Market News Thu, 11 Jul 2024 06:21:49 GMT
• pt vale indonesia tbk (otcmkts:ptndy) stock price down 19.2% American Banking and Market News Thu, 11 Jul 2024 06:21:49 GMT
• outokumpu oyj (otcmkts:outff) stock price down 7.5% American Banking and Market News Thu, 11 Jul 2024 06:21:49 GMT
• nfi group (otcmkts:nfyef) shares down 3.1% American Banking and Market News Thu, 11 Jul 2024 06:21:49 GMT
• financial comparison: rocket pharmaceuticals (nasdaq:rckt) & graybug vision (nasdaq:gray) Defense World Mon, 08 Jul 2024 05:39:14 GMT
• graybug announces name and trading symbol change to calcimedica, inc. and has changed its trading symbol to "calc" Quantisnow Fri, 28 Jun 2024 06:51:35 GMT
• ocular drug delivery market size to fly high as demand continues to increase Taiwan News Mon, 24 Jun 2024 07:00:00 GMT
• retinal disorders treatment market excessive growth opportunities estimated to be experienced by – timc TIMC Mon, 17 Jun 2024 05:47:53 GMT
• diabetic macular edema pipeline drugs analysis report, 2024: fda approvals, clinical trials, therapies, moa, roa by delveinsight |... Barchart Thu, 13 Jun 2024 07:00:00 GMT
• will graybug vision (nasdaq:gray) spend its cash wisely? Yahoo New Zealand News Tue, 28 May 2024 22:26:37 GMT
• will graybug vision (nasdaq:gray) spend its cash wisely? Yahoo New Zealand News Mon, 27 May 2024 03:16:04 GMT
• will graybug vision (nasdaq:gray) spend its cash wisely? Yahoo New Zealand News Sat, 25 May 2024 20:52:36 GMT
• head-to-head comparison: morphosys (nasdaq:mor) & graybug vision (nasdaq:gray) Defense World Sat, 18 May 2024 07:00:00 GMT
• diabetic macular edema market to observe impressive growth during the forecast period (2023-2032), evaluates ... openPR Tue, 14 May 2024 07:00:00 GMT
• wet age-related macular degeneration market and epidemiology 2032 openPR Wed, 08 May 2024 18:18:00 GMT
• age-related macular degeneration market to exhibit substantial growth rate | regeneron pharmaceuticals, novartis, roche, opthea li... Barchart.com Mon, 06 May 2024 07:00:00 GMT
• revopsis welcomes dr. emmett cunningham to strategic advisory board BioSpace Fri, 03 May 2024 07:00:00 GMT
• retinal disorder treatment market growth drivers | santen pharmaceutical, regeneron, graybug vision - motions ... Motions Online Tue, 30 Apr 2024 16:29:55 GMT
• visionary advances: illuminating the ocular drug delivery system market in 2024 as revealed in new report WhaTech Thu, 25 Apr 2024 07:00:00 GMT
• ocular drug delivery technology market size in 2024 share & comprehensive analysis till 2031 [ new report ] WICZ Tue, 23 Apr 2024 07:00:00 GMT
• ocular drug delivery technology industry global analysis (2024-2034) – post production buyers guide Post Production Buyers Guide Thu, 18 Apr 2024 15:35:11 GMT
• retinal vein occlusion market to rise by 2032, asserts delveinsight openPR Wed, 17 Apr 2024 12:01:00 GMT
• graybug vision to participate in the piper sandler 33rd annual virtual healthcare conference Quantisnow Tue, 02 Apr 2024 05:02:39 GMT
• retinal disorder treatment market growth drivers | santen pharmaceutical, regeneron, graybug vision Amoré Wed, 20 Mar 2024 08:04:12 GMT
• global diabetic macular edema treatment market by treatment GlobeNewswire Tue, 19 Mar 2024 07:00:00 GMT
• graybug vision (nasdaq:gray) trading down 3.6% - american banking and market news AmericanBankingNEWS Thu, 14 Mar 2024 05:52:55 GMT
• graybug vision to present at the 16th annual needham healthcare conference on april 4 Yahoo Singapore News Fri, 08 Mar 2024 21:01:26 GMT
• end in sight as opthea looks to be key player in us$10 billion wet amd market Stockhead Thu, 07 Mar 2024 08:00:00 GMT
• opthea looks to be key player in $us10 billion wet amd market The Mercury Thu, 07 Mar 2024 08:00:00 GMT
• ocular drug delivery market rising to new heights unleashing the power of market size growth | abbvie, allergan Taiwan News Fri, 01 Mar 2024 08:00:00 GMT
• vesper healthcare acquisition (otcmkts:vspru) stock price down 2.2% Defense World Wed, 21 Feb 2024 08:00:15 GMT
• calcimedica announces fda clearance of ind application for phase 2 trial of auxora for the treatment of severe ... Marketscreener.com Wed, 14 Feb 2024 12:12:37 GMT
• calcimedica gets fda nod for phase 2 trial of acute kidney injury with respiratory failure treatment Marketscreener.com Tue, 13 Feb 2024 21:10:28 GMT
• calcimedica announces fda clearance of ind application for phase 2 trial of auxora? for the treatment of severe ... Marketscreener.com Tue, 13 Feb 2024 13:00:00 GMT
• calcimedica to present at the oppenheimer 34th annual healthcare life sciences conference Marketscreener.com Wed, 07 Feb 2024 21:06:13 GMT
• graybug vision inc and calcimedica inc enter into definitive merger agreement call transcript GuruFocus.com Tue, 06 Feb 2024 09:11:27 GMT
• mireca medicines granted $1m for inherited retinal disease advancements Eyes On Eyecare Thu, 01 Feb 2024 08:00:00 GMT
• hc wainwright starts coverage on calcimedica with buy rating, $20 price target Marketscreener.com Mon, 29 Jan 2024 14:22:07 GMT
• calcimedica insider bought shares worth $2515080, according to a recent sec filing Marketscreener.com Fri, 26 Jan 2024 13:21:10 GMT
• retinal vein occlusion market to witness growth by 2032 | major players- abbvie, roche, regeneron pharmaceutic openPR Wed, 24 Jan 2024 15:49:00 GMT
• calcimedica secures $55 million funding deal with investors; shares gain Marketscreener.com Mon, 22 Jan 2024 16:48:06 GMT
• calcimedica announces private placement of up to approximately $55 million Marketscreener.com Mon, 22 Jan 2024 13:01:12 GMT
• calcimedica, inc. announced that it expects to receive $20.4 million in funding Marketscreener.com Thu, 18 Jan 2024 23:00:00 GMT
Graybug Vision, Inc(NASDAQ:GRAY) 
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb...
Website: http://www.graybug.com
Founded: 2011
Full Time Employees: 32 (May 2021)
CEO: Frédéric Guerard
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends